These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy. Millan MJ, Peglion JL, Vian J, Rivet JM, Brocco M, Gobert A, Newman-Tancredi A, Dacquet C, Bervoets K, Girardon S. J Pharmacol Exp Ther; 1995 Nov 04; 275(2):885-98. PubMed ID: 7473180 [Abstract] [Full Text] [Related]
3. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Millan MJ, Audinot V, Rivet JM, Gobert A, Vian J, Prost JF, Spedding M, Peglion JL. Eur J Pharmacol; 1994 Aug 01; 260(2-3):R3-5. PubMed ID: 7988633 [Abstract] [Full Text] [Related]
4. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297. Rivet JM, Audinot V, Gobert A, Peglion JL, Millan MJ. Eur J Pharmacol; 1994 Nov 24; 265(3):175-7. PubMed ID: 7875234 [Abstract] [Full Text] [Related]
5. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ. J Pharmacol Exp Ther; 1995 Nov 24; 275(2):899-913. PubMed ID: 7473181 [Abstract] [Full Text] [Related]
6. Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Lejeune F, Millan MJ. Eur J Pharmacol; 1995 Mar 14; 275(3):R7-9. PubMed ID: 7768288 [Abstract] [Full Text] [Related]
7. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors. Millan MJ, Girardon S, Monneyron S, Dekeyne A. Neuropharmacology; 2000 Feb 14; 39(4):586-98. PubMed ID: 10728880 [Abstract] [Full Text] [Related]
8. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ. J Pharmacol Exp Ther; 1998 Oct 14; 287(1):187-97. PubMed ID: 9765337 [Abstract] [Full Text] [Related]
9. Role of dopamine D3 receptors in thermoregulation: a reappraisal. Perachon S, Betancur C, Pilon C, Rostène W, Schwartz JC, Sokoloff P. Neuroreport; 2000 Jan 17; 11(1):221-5. PubMed ID: 10683862 [Abstract] [Full Text] [Related]
10. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen. Hillefors M, von Euler G. Neurochem Int; 2001 Jan 17; 38(1):31-42. PubMed ID: 10913686 [Abstract] [Full Text] [Related]
11. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT. Dekeyne A, Rivet JM, Gobert A, Millan MJ. Neuropharmacology; 2001 Jun 17; 40(7):899-910. PubMed ID: 11378160 [Abstract] [Full Text] [Related]
12. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors? Varty GB, Higgins GA. Behav Pharmacol; 1998 Sep 17; 9(5-6):445-55. PubMed ID: 9832930 [Abstract] [Full Text] [Related]
13. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study). Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS. Pharmacol Res; 2001 Mar 17; 43(3):283-90. PubMed ID: 11401421 [Abstract] [Full Text] [Related]
14. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors. Millan MJ, Iob L, Péglion JL, Dekeyne A. Psychopharmacology (Berl); 2007 Apr 17; 191(3):767-82. PubMed ID: 17047933 [Abstract] [Full Text] [Related]
15. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat. Eltayb A, Lindblom S, Oerther S, Ahlenius S. Acta Physiol Scand; 2001 Jul 17; 172(3):205-9. PubMed ID: 11472307 [Abstract] [Full Text] [Related]
16. The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats. Millan MJ, Gressier H, Brocco M. Eur J Pharmacol; 1997 Mar 05; 321(3):R7-9. PubMed ID: 9085054 [Abstract] [Full Text] [Related]
19. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors. Gonzalez AM, Sibley DR. Eur J Pharmacol; 1995 Jan 05; 272(1):R1-3. PubMed ID: 7713138 [Abstract] [Full Text] [Related]
20. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. Roberts C, Cummins R, Gnoffo Z, Kew JN. Eur J Pharmacol; 2006 Mar 18; 534(1-3):108-14. PubMed ID: 16490190 [Abstract] [Full Text] [Related] Page: [Next] [New Search]